These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4148957)

  • 1. [Therapeutic value of oxyphedrin (Ildamen) in treatment of ischemic heart disease].
    Giec L; Mandecki T; Hermanowicz A
    Wiad Lek; 1973 Dec; 26(23):2201-5. PubMed ID: 4148957
    [No Abstract]   [Full Text] [Related]  

  • 2. [The value of xamoterol in moderate ischemic cardiac insufficiency].
    Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
    Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of ildamen on the heart conduction system in ischemic heart disease patients].
    Shilov AM; Borisov VG
    Farmakol Toksikol; 1987; 50(5):34-6. PubMed ID: 2891566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of xamoterol in heart failure of ischemic origin.
    Marlow HF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S69-72. PubMed ID: 2478814
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of tobanum and visken in ischemic heart disease with extrasystole].
    Korkushko OV; Shatilo VB; Butenko AG
    Sov Med; 1989; (12):66-8. PubMed ID: 2483591
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of clinical studies of beta stimulating agents in the treatment of chronic heart disease].
    Metelutsa VI; Chazova LV; Grigor'iants RA; Krol VA; Trubetskoĭ AV
    Ter Arkh; 1977; 49(4):44-8. PubMed ID: 17171
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cordanum in the treatment of ischemic heart disease with stable extrasystole in the middle-aged and elderly].
    Korkushko OV; Butenko AG; Shatilo VB
    Sov Med; 1986; (8):3-8. PubMed ID: 2430340
    [No Abstract]   [Full Text] [Related]  

  • 8. [Duration of effect and dose-response relationship of a new beta-sympatholytic agent in comparison with pindolol in patients with coronary heart disease].
    Becker HJ; Matthäus EJ; Kaltenbach M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1690-4. PubMed ID: 19897
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of coronaroactive agents with beta-stimulating effect in ischemic heart disease].
    Kukes VG; Buianov VV; Semenov VN; Abugov AM; Borovkov AI
    Kardiologiia; 1976 Apr; 16(4):88-93. PubMed ID: 16157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of atenolol in moderate-to-mild essential hypertension and in ischemic cardiopathy. Evaluation with the bicycle ergometer].
    Mellini M; Robutti A; Mattiauda C; Cavazzana G; Roych C; Sanfelici D; Baccino M; Reforzo F
    Clin Ter; 1983 Mar; 104(5):391-4. PubMed ID: 6851445
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of coronary insufficiency. Comparative study on the effect of a nitro compound (isosorbidedinitrate), a beta sympatholytic (bupranolol) and a drug combination (oxycardin)].
    Philipp R; Kutscha W
    Med Welt; 1980 May; 31(21):817-20. PubMed ID: 7392937
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of the combined use of adrenergic beta receptor blockaders and long-acting nitrates in chronic ischemic heart disease].
    Bragina GI
    Klin Med (Mosk); 1981 Nov; 59(11):36-42. PubMed ID: 6119395
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of the action of dobutamine in acute cardiac insufficiency].
    Chevalier P; Leylavergne J; Gournay G; Laffay N; Gryman R; Renault C; Guérot C; Valère PE; Tricot R
    Ann Cardiol Angeiol (Paris); 1984; 33(4):227-32. PubMed ID: 6147116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Course of concomitant diseases in ischemic heart disease patients on long-term beta-blocker therapy].
    Zhuk AE; Broun LM; Mendelevich LA
    Klin Med (Mosk); 1986 Feb; 64(2):95-7. PubMed ID: 2871222
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of nadolol in coronary disease].
    Krotkiewski A; Zatorski A; Jarecki M; Ruszkowski J; Szelemetko J
    Pol Tyg Lek; 1980 Jun; 35(22):833-6. PubMed ID: 6106925
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of coronary disease with the beta-blocker betapressin].
    Christandl B
    Fortschr Med; 1981 Sep; 99(36):1473-6. PubMed ID: 6117510
    [No Abstract]   [Full Text] [Related]  

  • 17. [Improvement of the heart function in coronary patients after beta-adrenergic receptor blockers].
    Reale A; Nigri A; Gioffrè PA; D'Intino S
    Boll Soc Ital Cardiol; 1976; 21(8):1409-12. PubMed ID: 21673
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience with oxyphedrine. Action on the heart and coronary therapy (author's transl)].
    Castillo Bernal A; Sáez de Santa María IE
    Folia Clin Int (Barc); 1974; 24(7):573-8. PubMed ID: 4408919
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of nadolol in coronary disease].
    Tkaczewski W; Goch JH; Dziekański S
    Kardiol Pol; 1983; 26(3):215-9. PubMed ID: 6138456
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of betapressin on respiratory measurements and stress ECG in patients with coronary disease].
    Felder K
    Ther Ggw; 1981 Jun; 120(6):559-70. PubMed ID: 7281044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.